abstract |
The present invention relates to stabilized modified release vitamin D formulations and methods of administering the same. A stabilized formulation for controlled release of vitamin D compounds is disclosed. This formulation contains one or both of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 and a cellulose compound. Stabilized formulations exhibit stable dissolution profiles after exposure to storage conditions and exhibit improved pharmacokinetic parameters compared to unstabilized formulations. |